We can't solve problems by using the same kind of thinking we used when we created them.
— Albert Einstein
At Elpiscience, we take pride in our knowledge and abilities to tackle the delicate network of immune systems. We employ a comprehensive approach to cover key angles in immunology that affect tumor cells. Our product pipeline spans four major categories: adaptive immunity, innate immunity, tumor microenvironment, and tumor-specific antigens. This ensures that our approach would cover critical elements for therapeutic development.
We are passionate about novel targets and pathways in immuno-oncology, especially innate immunity where macrophages, dendritic cells and NK cells are the major players. We focus on suppressive factors and molecules within the tumor microenvironment. We see a plethora of opportunities here for discovering new tools to fight cancer. Our deep exploration into this area provides a high likelihood of uncovering the “next big thing” in cancer immunotherapy.
We are not working alone, though. Elpiscience collaborates closely with the top scientists around the world to make sure our knowledge and technologies are cutting-edge. We utilize the expertise of our scientific advisors to navigate the complex immune system and find cures for cancer.